Motor Neuron Diseases Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: MDA3E76D5B1FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Motor Neuron Diseases Treatment in Global, including the following market information:

Global Motor Neuron Diseases Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Motor Neuron Diseases Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Riluzole Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Motor Neuron Diseases Treatment include NIH, UCL Institute of Neurology, National Neuroscience Institute, The University of Melbourne, The University of Sheffield, OZBiosciences, The University of Queensland and MND Australia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Motor Neuron Diseases Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Motor Neuron Diseases Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Motor Neuron Diseases Treatment Market Segment Percentages, by Type, 2021 (%)

• Riluzole
• Nusinersen
• Physical Therapy
• Respiratory Therapy
• Others

Global Motor Neuron Diseases Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Motor Neuron Diseases Treatment Market Segment Percentages, by Application, 2021 (%)

• Multidisciplinary Clinics
• Hospitals
• Social Work Facilities
• Others

Global Motor Neuron Diseases Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Motor Neuron Diseases Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Motor Neuron Diseases Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Motor Neuron Diseases Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• NIH
• UCL Institute of Neurology
• National Neuroscience Institute
• The University of Melbourne
• The University of Sheffield
• OZBiosciences
• The University of Queensland
• MND Australia

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Motor Neuron Diseases Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Motor Neuron Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MOTOR NEURON DISEASES TREATMENT OVERALL MARKET SIZE

2.1 Global Motor Neuron Diseases Treatment Market Size: 2021 VS 2028
2.2 Global Motor Neuron Diseases Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Motor Neuron Diseases Treatment Players in Global Market
3.2 Top Global Motor Neuron Diseases Treatment Companies Ranked by Revenue
3.3 Global Motor Neuron Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Motor Neuron Diseases Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Motor Neuron Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Motor Neuron Diseases Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Motor Neuron Diseases Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Motor Neuron Diseases Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Motor Neuron Diseases Treatment Market Size Markets, 2021 & 2028
  4.1.2 Riluzole
  4.1.3 Nusinersen
  4.1.4 Physical Therapy
  4.1.5 Respiratory Therapy
  4.1.6 Others
4.2 By Type - Global Motor Neuron Diseases Treatment Revenue & Forecasts
  4.2.1 By Type - Global Motor Neuron Diseases Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Motor Neuron Diseases Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Motor Neuron Diseases Treatment Market Size, 2021 & 2028
  5.1.2 Multidisciplinary Clinics
  5.1.3 Hospitals
  5.1.4 Social Work Facilities
  5.1.5 Others
5.2 By Application - Global Motor Neuron Diseases Treatment Revenue & Forecasts
  5.2.1 By Application - Global Motor Neuron Diseases Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Motor Neuron Diseases Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Motor Neuron Diseases Treatment Market Size, 2021 & 2028
6.2 By Region - Global Motor Neuron Diseases Treatment Revenue & Forecasts
  6.2.1 By Region - Global Motor Neuron Diseases Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Motor Neuron Diseases Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Motor Neuron Diseases Treatment Revenue, 2017-2028
  6.3.2 US Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.3.3 Canada Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.3.4 Mexico Motor Neuron Diseases Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Motor Neuron Diseases Treatment Revenue, 2017-2028
  6.4.2 Germany Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.3 France Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.4 U.K. Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.5 Italy Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.6 Russia Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.4.8 Benelux Motor Neuron Diseases Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Motor Neuron Diseases Treatment Revenue, 2017-2028
  6.5.2 China Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.5.3 Japan Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.5.4 South Korea Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.5.6 India Motor Neuron Diseases Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Motor Neuron Diseases Treatment Revenue, 2017-2028
  6.6.2 Brazil Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.6.3 Argentina Motor Neuron Diseases Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Motor Neuron Diseases Treatment Revenue, 2017-2028
  6.7.2 Turkey Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.7.3 Israel Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Motor Neuron Diseases Treatment Market Size, 2017-2028
  6.7.5 UAE Motor Neuron Diseases Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 NIH
  7.1.1 NIH Corporate Summary
  7.1.2 NIH Business Overview
  7.1.3 NIH Motor Neuron Diseases Treatment Major Product Offerings
  7.1.4 NIH Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.1.5 NIH Key News
7.2 UCL Institute of Neurology
  7.2.1 UCL Institute of Neurology Corporate Summary
  7.2.2 UCL Institute of Neurology Business Overview
  7.2.3 UCL Institute of Neurology Motor Neuron Diseases Treatment Major Product Offerings
  7.2.4 UCL Institute of Neurology Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.2.5 UCL Institute of Neurology Key News
7.3 National Neuroscience Institute
  7.3.1 National Neuroscience Institute Corporate Summary
  7.3.2 National Neuroscience Institute Business Overview
  7.3.3 National Neuroscience Institute Motor Neuron Diseases Treatment Major Product Offerings
  7.3.4 National Neuroscience Institute Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.3.5 National Neuroscience Institute Key News
7.4 The University of Melbourne
  7.4.1 The University of Melbourne Corporate Summary
  7.4.2 The University of Melbourne Business Overview
  7.4.3 The University of Melbourne Motor Neuron Diseases Treatment Major Product Offerings
  7.4.4 The University of Melbourne Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.4.5 The University of Melbourne Key News
7.5 The University of Sheffield
  7.5.1 The University of Sheffield Corporate Summary
  7.5.2 The University of Sheffield Business Overview
  7.5.3 The University of Sheffield Motor Neuron Diseases Treatment Major Product Offerings
  7.5.4 The University of Sheffield Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.5.5 The University of Sheffield Key News
7.6 OZBiosciences
  7.6.1 OZBiosciences Corporate Summary
  7.6.2 OZBiosciences Business Overview
  7.6.3 OZBiosciences Motor Neuron Diseases Treatment Major Product Offerings
  7.6.4 OZBiosciences Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.6.5 OZBiosciences Key News
7.7 The University of Queensland
  7.7.1 The University of Queensland Corporate Summary
  7.7.2 The University of Queensland Business Overview
  7.7.3 The University of Queensland Motor Neuron Diseases Treatment Major Product Offerings
  7.7.4 The University of Queensland Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.7.5 The University of Queensland Key News
7.8 MND Australia
  7.8.1 MND Australia Corporate Summary
  7.8.2 MND Australia Business Overview
  7.8.3 MND Australia Motor Neuron Diseases Treatment Major Product Offerings
  7.8.4 MND Australia Motor Neuron Diseases Treatment Revenue in Global Market (2017-2022)
  7.8.5 MND Australia Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Motor Neuron Diseases Treatment Market Opportunities & Trends in Global Market
Table 2. Motor Neuron Diseases Treatment Market Drivers in Global Market
Table 3. Motor Neuron Diseases Treatment Market Restraints in Global Market
Table 4. Key Players of Motor Neuron Diseases Treatment in Global Market
Table 5. Top Motor Neuron Diseases Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Motor Neuron Diseases Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Motor Neuron Diseases Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Motor Neuron Diseases Treatment Product Type
Table 9. List of Global Tier 1 Motor Neuron Diseases Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Motor Neuron Diseases Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Motor Neuron Diseases Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Motor Neuron Diseases Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Motor Neuron Diseases Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Motor Neuron Diseases Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Motor Neuron Diseases Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Motor Neuron Diseases Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2023-2028
Table 30. NIH Corporate Summary
Table 31. NIH Motor Neuron Diseases Treatment Product Offerings
Table 32. NIH Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 33. UCL Institute of Neurology Corporate Summary
Table 34. UCL Institute of Neurology Motor Neuron Diseases Treatment Product Offerings
Table 35. UCL Institute of Neurology Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 36. National Neuroscience Institute Corporate Summary
Table 37. National Neuroscience Institute Motor Neuron Diseases Treatment Product Offerings
Table 38. National Neuroscience Institute Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 39. The University of Melbourne Corporate Summary
Table 40. The University of Melbourne Motor Neuron Diseases Treatment Product Offerings
Table 41. The University of Melbourne Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 42. The University of Sheffield Corporate Summary
Table 43. The University of Sheffield Motor Neuron Diseases Treatment Product Offerings
Table 44. The University of Sheffield Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 45. OZBiosciences Corporate Summary
Table 46. OZBiosciences Motor Neuron Diseases Treatment Product Offerings
Table 47. OZBiosciences Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 48. The University of Queensland Corporate Summary
Table 49. The University of Queensland Motor Neuron Diseases Treatment Product Offerings
Table 50. The University of Queensland Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)
Table 51. MND Australia Corporate Summary
Table 52. MND Australia Motor Neuron Diseases Treatment Product Offerings
Table 53. MND Australia Motor Neuron Diseases Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Motor Neuron Diseases Treatment Segment by Type in 2021
Figure 2. Motor Neuron Diseases Treatment Segment by Application in 2021
Figure 3. Global Motor Neuron Diseases Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Motor Neuron Diseases Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Motor Neuron Diseases Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Motor Neuron Diseases Treatment Revenue in 2021
Figure 8. By Type - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 12. US Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 24. China Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Motor Neuron Diseases Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Motor Neuron Diseases Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. NIH Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. UCL Institute of Neurology Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. National Neuroscience Institute Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. The University of Melbourne Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. The University of Sheffield Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. OZBiosciences Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. The University of Queensland Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MND Australia Motor Neuron Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)